Gabelli Healthcare & Wellnessrx Trust (GRX) Fundamental Analysis: Revenue, Earnings & Valuation

1.61 / 10

Underperform

Fundamental analysis scores 1.61/10, reflecting significant challenges in financial health. Key concerns include a rate of return on total assets of -10.07% and annualized return of -20.14%, both in the first performance group, indicating poor profitability. Earnings growth is negative, with basic EPS down 40.57% YoY and diluted EPS down 14.17% YoY. However, operating revenue shows a strong 392.77% YoY growth, and gross profit margin is a solid 38.11%. The current liabilities to total liabilities ratio of 52.14% is average. Overall, the fundamentals are selective, with growth offset by weak profitability.

Analysis Checks(3/8)

Gross profit margin (%)

Value38.11

Score2/3

Weight15.28%

1M Return1.53%

Current liabilities / Total liabilities (%)

Value52.14

Score2/3

Weight15.71%

1M Return1.58%

Basic earnings per share (YoY growth rate %)

Value-40.57

Score0/3

Weight4.75%

1M Return0.50%

Rate of return on total assets (%)

Value-10.07

Score1/3

Weight14.21%

1M Return1.48%

Total profit / EBIT (%)

Value100.00

Score2/3

Weight15.05%

1M Return1.52%

Annualized return on total assets (%)

Value-20.14

Score1/3

Weight14.21%

1M Return1.48%

Diluted earnings per share (YoY growth rate %)

Value-14.17

Score0/3

Weight8.30%

1M Return0.88%

Operating revenue (YoY growth rate %)

Value392.77

Score1/3

Weight12.48%

1M Return1.29%

Is GRX undervalued or overvalued?

GRX scores 1.61/10 on fundamentals and holds a Premium valuation at present. Backed by its -0.91% ROE, -18.73% net margin, -214.50 P/E ratio, 0.92 P/B ratio, and 0.00% earnings growth, these metrics solidify its Underperform investment rating.